Key result
Bilateral anterior quadratus lumborum block with ropivacaine did not reduce 24-hour morphine consumption compared to placebo in laparoscopic colorectal surgery (28.6 mg vs 28.4 mg, p=0.966).
Why the study?
The efficacy and safety of a bilateral anterior quadratus lumborum block in patients undergoing minimally invasive colorectal surgery required investigation.
Does a bilateral anterior quadratus lumborum block with ropivacaine reduce morphine consumption in patients undergoing minimally invasive colorectal surgery?
RCT (n=150)
Double-blind
randomly
Yes
Does a bilateral anterior quadratus lumborum block with ropivacaine reduce morphine consumption in patients undergoing minimally invasive colorectal surgery?
Adding a bilateral anterior quadratus lumborum block to a standard multimodal analgesia regimen does not reduce opioid consumption or improve pain scores in patients undergoing laparoscopic colorectal surgery.
Answers are grounded in this paper and cite their sources.
Does not support adding bilateral anterior quadratus lumborum block to multimodal analgesia in laparoscopic colorectal surgery; challenges smaller positive trials.
We investigated the efficacy and safety of a bilateral anterior quadratus lumborum block in patients undergoing minimally invasive colorectal surgery. This was a two-centre, double-blind, prospective, randomised, placebo-controlled trial including 150 patients undergoing laparoscopic colorectal surgery (left- or right hemicolectomy, sigmoidectomy) who were enrolled in the institutional abdominal enhanced recovery programme. Before induction of anaesthesia, patients received a bilateral anterior quadratus lumborum block in the left and right lateral decubitus position under ultrasound guidance and were allocated randomly to receive 30 ml of ropivacaine 0.375% (n = 75) or placebo (saline 0.9%) (n = 75) bilaterally. Postoperatively, all patients received multimodal intravenous analgesia including paracetamol, ketorolac and patient-controlled analgesia with morphine. The primary outcome was morphine consumption during the first 24 h after tracheal extubation. Secondary outcomes included severity of pain; presence and extent of sensory block; incidence of postoperative nausea and vomiting; and hospital duration of stay. We also investigated the need for, and dose of, rescue analgesia. Safety outcomes included the incidence of adverse events. Mean (SD) 24-hour morphine consumption was no different between patients allocated to ropivacaine and placebo (28.6 (22.3) mg vs. 28.4 (22.5) mg, p = 0.966, respectively). While a sensory block could be detected in significantly more patients allocated to the ropivacaine group, no differences were detected in pain scores or other secondary or safety endpoints. Patient satisfaction scores were high in both groups. In laparoscopic colorectal surgery, adding a bilateral anterior quadratus lumborum block to a standard multimodal analgesia regimen did not reduce opioid consumption or improve pain scores.
No takes yet. Share an insight, caveat, or question.
Coppens et al. (2023) conducted an RCT in minimally invasive colorectal surgery (n=150). Bilateral anterior quadratus lumborum block with ropivacaine vs. Placebo (saline 0.9%) bilaterally was evaluated on Morphine consumption during the first 24 h after tracheal extubation (p=0.966). Bilateral anterior quadratus lumborum block with ropivacaine did not reduce 24-hour morphine consumption compared to placebo in laparoscopic colorectal surgery (28.6 mg vs 28.4 mg, p=0.966).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: